参考文献/References:
[1] 惠凌云,王凌,张琳,等.CHB 患者疾病进程与抑郁症的程度及血清 BDNF 水平的相关性[J].现代检验医学杂志,2015,30(3):13-16. HUI Lingyun, WANG Ling, ZHANG Lin, et al. Correlation of the disease process,depression severity and serum levels of BDNF in patient with CHB [J]. Journal of Modern Laboratory Medicine, 2015,30(3):13-16.
[2] SCHOSSER A, SERRETTI A, SOUERY D, et al. European group for the study of resistant depression(GSRD)-where have we gone so far: review of clinical and genetic findings[J]. European Neuropsychopharmacology, 2012, 22(7): 453-468.
[3] SCHNEIDER B, PRVULOVIC D. Novel biomarkers in major depression[J]. Current Opinion in Psychiatry, 2013, 26(1): 47-53.
[4] FLINT J, KENDLER K S. The genetics of major depression[J]. Neuron, 2014, 81(3): 484-503.
[5] CLARKE H, FLINT J, ATTWOOD A S, et al. Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis[J]. Psychological Medicine, 2010, 40(11): 1767-1778.
[6] 邓佳慧,李素霞,董问天,等.难治性抑郁症发病机制的研究进展[J].中国神经精神疾病杂志,2014,40(2):123-126. DENG Jiahui, LI Suxia, DONG Wentian, et al. Research progress on pathogenesis of resistant depression [J].Chinese Journal of Nervous and Mental Diseases,2014,40(2):123-126.
[7] KENDLER K S, AGGEN S H, NEALE M C. Evidence for multiple genetic factors underlying DSM-IV criteria for major depression[J]. JAMA Psychiatry, 2013, 70(6): 599-607.
[8] BAFFA A, HOHOFF C, BAUNE B T, et al. Norepinephrine and serotonin transporter genes: impact on treatment response in depression[J]. Neuropsychobiology, 2010, 62(2): 121-131.
[9] ILLI A, POUTANEN O, SETA LA-SOIKKELI E, et al. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD[J]. European Archives of Psychiatry and Clinical Neuroscience, 2011, 261(2): 95-102.
[10] REIMHERR F, AMSTERDAM J, DUNNER D, et al. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine[J]. Psychiatry Research, 2010, 175(1/2): 67-73.
[11] KIM H, LIM S W, KIM S, et al. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression[J]. Journal of the American Medical Association, 2006, 296(13): 1609-1618.
[12] MANOHARAN A,SHEWADE D G,RAJKUMAR R P, et al. Serotonin transporter gene(SLC6A4)polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients[J]. Eur J Clin Pharmacol,2016,72(10):1215-1220.
[13] DE CARLO V,CALATI R,SERRETTI A. Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review [J]. Psychiatry Res,2016,240:421-430.
[14] YOSHIMATSU K, ROSEN B H, KUNG S, et al. Improvements in depression severity in hospitalized patients with and without borderline personality features[J]. Journal of Psychiatric Practice, 2015, 21(3): 208-213.
[15] 武文珺,吴迪,王莹,等.难治性抑郁症患者人格特征分析[J].神经疾病与精神卫生,2018,18(4):264-266.WU Wenjun,WU Di,WANG Ying,et al. Study on personality traits of patients with treatment-resistant depression[J]. Journal of Neuroscience and Mental Health,2018,18(4):264-266.
[16] LEVENSON J C,WALLACE M L,FOURNIER J C, et al. The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy [J]. Consult Clin Psychol, 2012, 80(5): 719–729.
[17] HAKULINEN C, ELOVAINIO M, PULKKI-RABACK L, et al. Personality and depressive symptoms: individual participant meta-analysis of 10 cohort studies[J]. Depression and Anxiety, 2015, 32(7): 461-470.
[18] TSAI S J, HONG C J, CHENG C Y. Serotonin transporter genetic polymorphisms and harm avoidance in the Chinese[J]. Psychiatric Genetics, 2002, 12(3): 165-168.
[19] CULVERHOUSE R C, BOWES L, BRESLAU N, et al. Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression [J]. BMC Psychiatry, 2013, 13(1): 304-315.
[20] 柴巧莲,明庆森,张芸,等.5-羟色胺转运体基因启动子连锁区域多态性与应激的交互效应对青少年焦虑症状预测作用的纵向研究[J].中华行为医学与脑科学杂志,2014,23(3):196-199. CHAI Qiaolian,MING Qingsen,ZHANG Yun,et al. Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts anxiety symptoms in adolescents: a multi-wave longitudinal study [J].Chinese Journal of Behavioral Medicine and Brain Science,2014,23(3): 196-199.
[21] MANDELLI L, MARINO E, PIROVANO A, et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment[J]. European Neuropsychopharmacology, 2009,19(1): 64-67.
[22] ZAHN R, LYTHE K E, GETHIN J A, et al. The role of self-blame and worthlessness in the psychopathology of major depressive disorder[J]. Journal of Affective Disorders, 2015, 186: 337-341.